GT200200183A - Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol - Google Patents
Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazolInfo
- Publication number
- GT200200183A GT200200183A GT200200183A GT200200183A GT200200183A GT 200200183 A GT200200183 A GT 200200183A GT 200200183 A GT200200183 A GT 200200183A GT 200200183 A GT200200183 A GT 200200183A GT 200200183 A GT200200183 A GT 200200183A
- Authority
- GT
- Guatemala
- Prior art keywords
- heterocicloalquilsulfonil
- pirazol
- procedure
- prepare derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A PROCEDIMIENTOS PARA PREPARAR DERIVADOS DE HETEROCICLOALQUILSULFONIL PIRAZOL DE FORMULA GENERAL (I) EN DONDE R1,R2,R3,R4, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SE CREE QUE INHIBEN LA BIOSINTESIS DE PROSTAGLANDINAS POR INTERVENCION DE LA ACCION DE LA ENZIMA CICLOOXIGENASA SOBRE EL ACIDO ARAQUIDONICO POR LO QUE SON DE UTILIDAD EN CUADROS INFLAMATORIOS TALES COMO ARTRITIS, NEURODEGENERACION Y CUADROS NEOPLASICOS COMO CANCER DE COLON.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32564701P | 2001-09-28 | 2001-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200200183A true GT200200183A (es) | 2003-05-23 |
Family
ID=23268786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200200183A GT200200183A (es) | 2001-09-28 | 2002-09-12 | Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6646128B2 (es) |
| EP (1) | EP1430046A1 (es) |
| JP (1) | JP2005504127A (es) |
| KR (1) | KR20040039424A (es) |
| CN (1) | CN1561339A (es) |
| AR (1) | AR036680A1 (es) |
| BR (1) | BR0212860A (es) |
| CA (1) | CA2457798A1 (es) |
| CZ (1) | CZ2004414A3 (es) |
| GT (1) | GT200200183A (es) |
| HU (1) | HUP0401914A3 (es) |
| IL (1) | IL160369A0 (es) |
| MX (1) | MXPA04002879A (es) |
| PA (1) | PA8555601A1 (es) |
| PE (1) | PE20030532A1 (es) |
| PL (1) | PL370110A1 (es) |
| RU (1) | RU2004109148A (es) |
| UY (1) | UY27453A1 (es) |
| WO (1) | WO2003029244A1 (es) |
| ZA (1) | ZA200401043B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1865955A4 (en) * | 2005-03-25 | 2009-04-15 | Merck & Co Inc | TREATMENT OF MALE-HUMAN HUMANS BY TESTOSTERONE SUPPLEMENTATION ASSOCIATED WITH 5ALPHA-REDUCTASE INHIBITOR |
| MX2010000846A (es) * | 2007-07-23 | 2010-04-21 | Univ Hong Kong Chinese | Diagnostico de aneuploide cromosomico fetal mediante el uso de secuenciacion genomica. |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| IL104311A (en) | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5434178A (en) | 1993-11-30 | 1995-07-18 | G.D. Searle & Co. | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation |
| US5475018A (en) | 1993-11-30 | 1995-12-12 | G. D. Searle & Co. | 1,5-diphenyl pyrazole compounds for treatment of inflammation |
| RU2139281C1 (ru) | 1993-11-30 | 1999-10-10 | Джи Ди Сирл энд Компани | Пиразолилзамещенный бензолсульфонамид или его фармацевтически приемлемая соль, фармацевтическая композиция, способ лечения от воспаления или связанного с воспалением заболевания |
| US5401765A (en) | 1993-11-30 | 1995-03-28 | G. D. Searle | 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
| JPH10504542A (ja) | 1994-07-27 | 1998-05-06 | ジー．ディー．サール アンド カンパニー | 炎症処置用の置換チアゾール化合物 |
| US5620999A (en) | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
| US5585504A (en) | 1994-09-16 | 1996-12-17 | Merck & Co., Inc. | Process of making cox-2 inhibitors having a lactone bridge |
| DE69529690T2 (de) | 1994-12-21 | 2003-11-13 | Merck Frosst Canada & Co., Halifax | Diaryl-2(5h)-fuaranone als cox-2-inhibitoren |
| US5691374A (en) | 1995-05-18 | 1997-11-25 | Merck Frosst Canada Inc. | Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors |
| US5756529A (en) | 1995-09-29 | 1998-05-26 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies |
| GB9520584D0 (en) | 1995-10-09 | 1995-12-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| UA57002C2 (uk) | 1995-10-13 | 2003-06-16 | Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. | Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування |
| ATE212343T1 (de) | 1995-10-30 | 2002-02-15 | Merck Frosst Canada Inc | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren |
| EP1104759B1 (en) | 1999-12-03 | 2003-10-22 | Pfizer Products Inc. | Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| CA2392931A1 (en) * | 1999-12-03 | 2001-06-07 | Pfizer Products Inc. | Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| DE60004001T2 (de) * | 1999-12-03 | 2004-04-15 | Pfizer Products Inc., Groton | Acetylenderivate zur Verwendung als schmerzstillendes oder entzündungshemmendes Mittel |
-
2002
- 2002-09-12 GT GT200200183A patent/GT200200183A/es unknown
- 2002-09-19 JP JP2003532493A patent/JP2005504127A/ja active Pending
- 2002-09-19 CZ CZ2004414A patent/CZ2004414A3/cs unknown
- 2002-09-19 PL PL02370110A patent/PL370110A1/xx not_active Application Discontinuation
- 2002-09-19 IL IL16036902A patent/IL160369A0/xx unknown
- 2002-09-19 CN CNA028191625A patent/CN1561339A/zh active Pending
- 2002-09-19 WO PCT/IB2002/003908 patent/WO2003029244A1/en not_active Application Discontinuation
- 2002-09-19 HU HU0401914A patent/HUP0401914A3/hu unknown
- 2002-09-19 EP EP02760508A patent/EP1430046A1/en not_active Withdrawn
- 2002-09-19 KR KR10-2004-7004437A patent/KR20040039424A/ko not_active Application Discontinuation
- 2002-09-19 RU RU2004109148/04A patent/RU2004109148A/ru not_active Application Discontinuation
- 2002-09-19 CA CA002457798A patent/CA2457798A1/en not_active Abandoned
- 2002-09-19 MX MXPA04002879A patent/MXPA04002879A/es unknown
- 2002-09-19 BR BR0212860-8A patent/BR0212860A/pt not_active IP Right Cessation
- 2002-09-25 UY UY27453A patent/UY27453A1/es not_active Application Discontinuation
- 2002-09-26 AR ARP020103634A patent/AR036680A1/es unknown
- 2002-09-26 PE PE2002000951A patent/PE20030532A1/es not_active Application Discontinuation
- 2002-09-27 US US10/256,432 patent/US6646128B2/en not_active Expired - Fee Related
- 2002-09-27 PA PA20028555601A patent/PA8555601A1/es unknown
-
2003
- 2003-08-25 US US10/648,588 patent/US6846930B2/en not_active Expired - Fee Related
-
2004
- 2004-02-09 ZA ZA200401043A patent/ZA200401043B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2004414A3 (cs) | 2004-12-15 |
| WO2003029244A8 (en) | 2003-09-04 |
| KR20040039424A (ko) | 2004-05-10 |
| AR036680A1 (es) | 2004-09-29 |
| US6846930B2 (en) | 2005-01-25 |
| US20040044042A1 (en) | 2004-03-04 |
| PE20030532A1 (es) | 2003-06-18 |
| PL370110A1 (en) | 2005-05-16 |
| HUP0401914A2 (hu) | 2005-01-28 |
| US6646128B2 (en) | 2003-11-11 |
| WO2003029244A1 (en) | 2003-04-10 |
| US20030100765A1 (en) | 2003-05-29 |
| ZA200401043B (en) | 2005-04-15 |
| IL160369A0 (en) | 2004-07-25 |
| MXPA04002879A (es) | 2004-07-15 |
| UY27453A1 (es) | 2003-04-30 |
| CN1561339A (zh) | 2005-01-05 |
| RU2004109148A (ru) | 2005-08-20 |
| JP2005504127A (ja) | 2005-02-10 |
| EP1430046A1 (en) | 2004-06-23 |
| HUP0401914A3 (en) | 2006-04-28 |
| CA2457798A1 (en) | 2003-04-10 |
| BR0212860A (pt) | 2004-10-13 |
| PA8555601A1 (es) | 2003-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200500103A (es) | 4-fenilamino-quinazolin-6-il-amidas | |
| BRPI0512690A (pt) | análogos de fosfonato de compostos inibidores de hiv | |
| UY29886A1 (es) | Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones | |
| GT200300296A (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| GT200600444A (es) | Compuestos anti-hipercolesterolemicos | |
| GT200500008A (es) | Intermediarios de quinolina como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos | |
| MA29539B1 (fr) | Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one | |
| BRPI0415855A (pt) | processo para preparação de ésteres de ácido 2-dihalogenacil-3-amino-acrìlico e ésteres de ácido 3-dihalogeno-metil-pirazol-4-carboxìlico | |
| NZ580226A (en) | Dimer compounds as inhibitors of iap | |
| GT200300087A (es) | 2-(2,6-diclorofenil)-diarilimidazoles | |
| ECSP10010129A (es) | Inhibidores de quinasas símil polo | |
| UY29360A1 (es) | Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones. | |
| CR9463A (es) | Pirrolinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion | |
| BRPI0702269A (pt) | alcanolamidas e uso do mesmo como aditivos de combustìvel | |
| RS53679B1 (en) | FURAZANOBENZIMIDAZOLES AS PROGRAMS FOR THE TREATMENT OF NEOPLASTIC OR AUTOIMMUNE DISEASES | |
| GT200300033A (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
| CU20090009A7 (es) | Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios | |
| ATE449098T1 (de) | Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole | |
| GT200600208A (es) | Compuestos organicos | |
| GT200600305A (es) | Métodos para preparar derivados de acido glutamico | |
| GT200300271A (es) | Derivados del acido isoftalico | |
| EA200702428A1 (ru) | Способы получения 4-бифенилилазетидин-2-онов | |
| GT200200183A (es) | Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol | |
| GT200300083A (es) | Inhibidores selectivos de la ciclooxigenasa-2 | |
| GT200500317A (es) | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos |